

HY-P9986 · 1 mg
MedChemExpress · Cat: HY-P9986
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/tiragolumab.html
Description
Tiragolumab is an immune checkpoint inhibitor binding to the T-cell immunoglobulin and ITIM domain TIGIT . Tiragolumab in combination with Atezolizumab HY-P9904 and Bevacizumab HY-P9906 has benefit in unresectable hepatocellular carcinoma. Tiragolumab can be used to study non-small cell lung cancer NSCLC and melanoma.







